Media Coverage header image

Media Coverage

Advanced Search
  • 07112022
    Healthcare IT Today

    The following is a guest article by Tom Romeo, General Manager of Healthcare IT at Quest Diagnostics. With a consistent approach, healthcare professionals can increase efficiency, timeliness and legibility, and better consistency and completeness of patient documentation. Ultimately, these benefits can also improve patient care and quality of service. Specifically, Intelligent Data Capture (IDC) is a tool that can help save time and money – and therefore improve care – by innovatively processing, classifying, extracting, validating and routing materials.

  • 07072022
    360Dx

    Quest Diagnostics said Thursday that it is participating in the CDC's Increasing Community Access to Testing (ICATT) for COVID-19 program. Through the program, Quest will provide $0 out-of-pocket COVID-19 testing to qualifying uninsured individuals at roughly 1,200 of the company's 2,100 patient service centers.

  • 06302022
    Becker's Hospital Review

    As healthcare workers continue to leave the industry at startling rates, health systems must find more effective ways to attract and retain employees. In a June Becker's Hospital Review webinar sponsored by Quest Diagnostics, three healthcare executives discussed current workforce challenges, creative attraction and retention strategies and the results that have been achieved. And how intentional initiatives that focus on helping employees feel like they belong, have a career advancement path, and focus on wellness have also been proven to be effective.

  • 06272022
    Healio

    Following updated hepatitis C virus screening recommendations issued in 2020, HCV screening in pregnancy accelerated across the country, according to a retrospective cohort study published in Obstetrics & Gynecology. “We wanted to see whether or not the revised guidelines — which came out during the COVID-19 pandemic — had an impact in changing physician [HCV screening] ordering patterns,” Harvey W. Kaufman, MD, MBA, FCAP, a senior medical director at Quest Diagnostics in Secaucus, New Jersey, told Healio.

  • 06222022
    Yahoo! News

    Quest Diagnostics has been recognized by the American Heart Association to receive their 2022 Award for Meritorious Achievement for our commitment to health care equity. Quest is removing barriers to health care for people in under-served communities and encouraging diversity in health care professionals through sponsorship of the AHA’s Historically Black Colleges and Universities Scholars Program and the Hispanic Serving Institutions Scholars Program.

  • 06202022
    HealthDay

    There has been substantial progress in the proportion of pregnant persons screened for hepatitis C virus, but the testing rates are still low, according to an article published in Obstetrics & Gynecology. Harvey W. Kaufman, M.D., from Quest Diagnostics in Secaucus, New Jersey, and colleagues examined the effect of the 2020 U.S. Centers for Disease Control and Prevention and U.S. Preventive Services Task Force recommendations on HCV screening among pregnant persons.

  • 06162022
    Inside Precision Medicine

    While there have been opportunities to apply digital pathology technologies for some time for secondary consultations, training and educational settings, and to review cases involving specialty stains, the ability to use digital pathology for a primary read is fairly new,” noted Kristie Dolan, vice president and general manager of oncology at Quest Diagnostics.

  • 06132022
    Lab Pulse

    A joint study conducted by Quest Diagnostics and the U.S. Centers for Disease Control and Prevention (CDC) has found that while the rate of hepatitis C (HCV) antibody screening increased 145% in pregnant people during the decade-long study period ending in June 2021, less than half of all pregnant people were screened in early 2021.

  • 06082022
    MedCity News

    In 2020, Covid-19 prompted a delay of non-urgent in-person medical care and concurrently exacerbated contributors to substance use disorders, including job loss, economic hardship and mental health issues. A Health Trends report from Quest Diagnostics found that 70% of physicians fear they missed signs of drug misuse during the pandemic, and the large majority fear overdose deaths will continue to rise even as the pandemic subsides.

  • 06062022
    Choose Healthy Life

    Governor Kathy Hochul today recognized Choose Healthy Life for its work during the pandemic for offering COVID-19 testing and vaccinations through its Black churches across the five boroughs of New York. The state’s commitment is part of a public-private collaboration that includes funding support from founding CHL partner Quest Diagnostics Foundation to hire the church-based community health workforce that has been established in New York and engaging the underserved communities in preventive care and wellness.

  • 06022022
    Yahoo! News

    Quest for Health Equity (Q4HE) and several Quest employees participated in an Earth Day weekend community event with the Black Church Food Security Network; an association of congregations, farmers, food advocates, and community activists working together to create an alternative food system in the Baltimore metropolitan area.

  • 06012022
    Clinical Lab Manager

    Before the COVID-19 pandemic, at Quest Diagnostics, we were in the midst of challenging what a traditional lab looked like to enhance quality, capacity, and efficiency while improving the employee experience. We remained committed to moving our East Region lab operations from our legacy lab in Teterboro, NJ, to Clifton, NJ, despite the pandemic challenges. The Clifton lab was built for our employees, with our employees.

  • 05272022
    360Dx

    As drugs to treat Alzheimer's disease come to market, led by the US Food and Drug Administration approval of Biogen's Aduhelm nearly a year ago, diagnostic tests to detect the disease are following suit. Blood-based biomarker tests have gained particular prominence, as they're less invasive and cheaper than both PET imaging and cerebrospinal fluid (CSF) biomarker testing – two current standards of care for patients presenting with Alzheimer's symptoms. Michael Racke, medical director for neurology at Quest Diagnostics, said in an interview that plasma tests are beneficial because they can be used to screen patients who are "normal cognitively" and may be candidates for intervention before they decline.

  • 05262022
    Health

    "Allergy and Omicron symptoms may mimic one another," Jeffrey Dlott, MD, senior medical director at Quest Diagnostics, told Health. "Because of this, someone may confuse COVID symptoms for allergy symptoms and not take the proper precautions to reduce spread." Here's what to know about how similar Omicron symptoms can look compared to allergies, and steps to take to confirm either diagnosis.

  • 05262022
    Clinical Lab Products

    Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients. However, to fully realize its potential there will need to be a paradigm shift with a focus on primary care physicians and collaboration across the healthcare enterprise. By Yuri Fesko, MD

  • 05232022
    Eat This, Not That!

    Springtime can be a beautiful time of year. Flowers are blooming, trees are budding, and vibrant colors are simply popping out all over. If you deal with seasonal allergies, though, the side effects aren't too pretty. We spoke with Dr. Jeffrey Dlott, Medical Director, QuestDirect to get the lowdown on the ugly side effects of seasonal allergies.

  • 05172022
    American Journal of Managed Care

    By predicting which individuals are most likely to require therapies for chronic kidney disease within the next year, health plans can better organize resource allocation to smooth or delay the transition for the patient, according to Rehan Waheed, MD of Quest Diagnostics.

  • 05172022
    EHS Today

    The rate of positive drug test results among America’s workforce in 2021 reached its highest level since 2001 and was up more than 30% in the combined workforce from an all-time low in 2010-2012, Quest Diagnostics’ annual Drug Testing Index found. Although year-over-year comparisons showed only small increases in 2021 over 2020, Quest said it rose substantially over the previous five years in most drug categories.

  • 05132022
    NeurologyLive

    A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.

  • 05122022
    Healthcare Business Today

    "2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health and COVID-19, and what it takes to compete for today's scarcest resource–people.

  • 05112022
    Becker's Hospital Review

    A majority of physicians believe medicine is on the verge of groundbreaking new treatments for Alzheimer's disease, according to research from Quest Diagnostics.

  • 05112022
    360Dx

    While value-based care contracts have long played a role in the lab industry, recent comments by Quest Diagnostics executives suggest that such arrangements are growing more prominent and more profitable.

  • 05102022
    BenefitsPRO Magazine

    As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy might be critical not only to keeping employees well but also keeping them at work. The “2022 Health at Work” report, released by Quest Diagnostics, addresses such hot-button topics as the changing world of work, employee health, and COVID-19.

  • 05092022
    The Pathologist

    Digital pathology is here to stay – and we need to embrace it. About the Author: Martin Potash is Managing Director of AmeriPath Denver, Quest Diagnostics, Colorado, USA.

  • 05042022
    MedCity News

    Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early detection typically relies on costly methods such as brain imaging and cerebrospinal fluid taps. Blood tests like the one developed by Quest promise to make detection easier, less costly and more accessible.

  • 04292022
    HuffPost

    Testicular cancer is highly treatable when diagnosed before reaching advanced stages, and like most cancers, early detection is key in helping to combat it. It’s recommended that males perform routine self-testicular exams, especially between the ages of 18 and 40, and pay close attention to any new findings such as changes of size of the testicle, differences with new firm areas or bumps that have not been there before. "Whether you’re regularly going to the doctor’s office or not, anyone with testicles should administer an at-home check every month or so,” said Dr. Jeffrey Dlott, the medical director of QuestDirect.

  • 04272022
    Health Professional Radi

    Returning guest, Dr. Jeffrey Dlott, Medical Director at QuestDirect, discusses the new “Future of Personalized Healthcare Insights Study 2022” that was conducted by Leaf Group in collaboration with QuestDirect and Well+Good. The study provides a deeper understanding of perceptions and preferences around telehealth, health data usage, and tech adoption, as well as ways to improve a patient’s healthcare journey.

  • 04262022
    360Dx

    Some in the clinical lab space are concerned that the US Centers for Disease Control and Prevention's recently updated draft guidelines for prescribing opioids downplays the role of toxicology testing in patient monitoring and management. Jeff Gudin, an anesthesiologist and pain management specialist at the University of Miami, Miller School of Medicine as well as senior medical advisor to Quest Diagnostics' drug monitoring and toxicology franchise, said that toxicology testing is essential to physician's understanding of what other drugs might be in a patient's system and whether or not they are using their medication as prescribed.

  • 04202022
    Axios

    The rate of American workers testing positive for cocaine and marijuana is at its highest point since 2001, according to an analysis from Quest Diagnostics. The Quest study is based on more than 11 million de-identified urine, hair and oral fluid drug test results collected between January and December 2021.

  • 04192022
    Boston Business Journal

    Quest Diagnostics, as part of its Quest for Health Equity initiative, is providing a grant for SAT college prep and AP courses for 300 students who are economically disadvantaged. Through conversations with the city of Marlborough's mayor's office and the Marlborough Economic Development Corporation, Quest became aware of the large number of high school students who do not have access to college-prep programs due to financial hardship.

  • 04142022
    Medical Laboratory Observer

    Quest Diagnostics announced a collaboration with IRIS (Intelligent Retinal Imaging Systems) to deliver diabetic retinal imaging services through designated Quest Diagnostics patient service centers across the United States to aid in screening patients for retinal assessment by a healthcare provider, according to a news release.

  • 04122022
    South Florida Sun-Sentinel

    Jay Wohlgemuth, chief medical officer at Quest Diagnostics, said competing laboratories, manufacturers and academics are working together to compile data and come up with messaging for how to use the test results that federal regulators will approve.

  • 04072022
    Food Tank

    Through a thoughtful agrarian-focused program with roots in one of the nation’s poorest communities in the South Bronx, the Green Bronx Machine cultivates a one-of-a-kind experience through hands-on activities related to planting, growing, cooking, and eating nutritious food. This spring, GBM is expanding its reach as they team up with the Quest Diagnostics Foundation, as part of the Quest for Health Equity (Q4HE) initiative, expanding the esteemed Green Bronx Machine Classroom Curriculum to 30 more schools in New York, Colorado, and Ohio reaching 15,000 additional students across the US.

  • 04072022
    Medical Economics

    Quest Diagnostics recently surveyed over 500 physicians in coordination with The Harris Poll to uncover attitudes about the rising drug overdose crisis and the role of clinical drug testing in safely prescribing opioids. A key theme emerged from the findings: physicians believe clinical drug testing is critical for managing opioids and other prescribed controlled medications, but feel clearer guidelines are needed to help optimize its use.

  • 04062022
    NJBIZ

    Diabetic retinopathy is the leading cause of blindness in the U.S., according to the Centers for Disease Control and Prevention. Now, an expanded collaboration between Quest Diagnostics and IRIS (Intelligent Retinal Imaging Systems) aims to increase convenience and improve screening rates for this condition.

  • 04052022
    Well + Good

    As society begins to open back up again, we wanted to know your thoughts on health care and what you personally need to live fully. So together with QuestDirect™—a service from Quest Diagnostics® that makes it easy to buy lab tests online for at-home or in-person collection without visiting a doctor first—we asked Well+Good readers in a survey, and over 1,400 of you responded.

  • 04042022
    Fortune

    Working Americans tested positive for drugs last year at the highest rate in more than two decades, mostly due to an increase in positive marijuana tests, according to research from Quest Diagnostics.

  • 03312022
    Well + Good

    Allergy responses start because you've come in contact with allergens, but a lot of them might be invisible to you, says Harvey Kaufman, MD, senior medical director at Quest Diagnostics, with a specialization in allergy testing. "Understanding the cause of your allergies and identifying sensitivity plays a pivotal role in managing seasonal allergies," Dr. Kaufman says.

  • 03302022
    Axios

    Positive drug tests among U.S. workers hit the highest level since 2001 last year, according to an analysis released Wednesday by Quest Diagnostics, one of the largest drug-testing laboratories in the country.

  • 03292022
    The Wall Street Journal

    The percentage of working Americans testing positive for drugs hit a two-decade high last year, driven by an increase in positive marijuana tests, as businesses might have loosened screening policies amid nationwide labor shortages. Of the more than six million general workforce urine tests that Quest Diagnostics Inc., one of the country’s largest drug-testing laboratories, screened for marijuana last year, 3.9% came back positive, an increase of more than 8% from 2020, according to Quest’s annual drug-testing index.

  • 03242022
    Medical Device and Diagnostic Industry

    COVID-19 mandates in the U.S. are loosening or in some cases the restrictions are being eliminated. However, one thing that remains strong is the desire to understand more about the respiratory disease, which is caused by the SARS-CoV-2. To that end, the Centers of Disease and Control and Prevention has contracted Quest Diagnostics to employ a comprehensive menu of COVID-19 antibody tests and data analytics services to research the disease. Quest won the $19.5 million contract in a competitive bid.

  • 03162022
    Lab Pulse

    The Quest Diagnostics Foundation has donated $500,000 to Project Health Opportunities for People Everywhere (HOPE) to aid humanitarian crisis relief for Ukraine and for Ukrainian refugees in Eastern Europe.

  • 03032022
    The Wall Street Journal

    The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products. Manufacturers are developing new types of at-home tests, including for flu and strep throat, aimed at consumers who are increasingly monitoring and managing their own health through fitness apps and smartwatches. Cathy Doherty, an executive at Quest in charge of the consumer-testing business, said Quest’s research shows that consumers are interested in a wider range of at-home tests, but many still prefer visiting a doctor’s office or testing center to make sure the tests are performed correctly.

  • 02252022
    Yahoo! News

    Choose Healthy Life's lead church in Newark, Metropolitan Baptist Church and its Senior Pastor Rev. Dr. David Jefferson Sr. Esq., along with all the pastors from Choose Healthy Life churches in the city joined with the Mayor of Newark Ras Baraka and Choose Healthy Life Founder Debra Fraser-Howze to acknowledge the major contribution of the Black clergy to address the COVID-19 pandemic with testing and vaccination events. “We saw firsthand the disproportionate impact COVID-19 had on the Black community and the vast health inequities it unveiled,” said Ruth Clements, Vice President and General Manager of Infectious Diseases & Immunology and leader for Quest for Health Equity at Quest Diagnostics.

  • 02242022
    The Dark Report

    Serving consumers interested in ordering their own clinical laboratory tests is a goal in an expanded collaboration involving Quest Diagnostics and Walmart. This is also consistent with The Dark Report’s prediction that retail pharmacies are poised to expand the diagnostic testing services they offer to customers. The development gives Quest a greater chance to meet patients online while also capitalizing on the growing familiarity of consumer-initiated testing, said Cathy Doherty, Senior Vice President and Group Executive of Clinical Franchise Solutions and Marketing at Quest.

  • 02142022
    NBC New York

    Businesses are in a hiring spree in the middle of what’s called “the Great Resignation.” Meanwhile, they’re also working to keep their current employees by conducting the opposite of an exit interview. The number one reason employees stay or leave is how much they trust their immediate supervisor. It's a message that resonated with Cecilia McKenney, the head of human resources for Quest's 50,000 employees.

  • 02082022
    Prevention

    A new study found an increasing amount of younger adults are being diagnosed with colorectal, rectal, and colon cancer. The research found those in their 20’s had a 133% increase in rectal-only, distant-stage cancer over a 16 year period. Doctors continue to encourage getting colon cancer screenings and talking to your doctor about family health history. Harvey Kaufman, M.D., senior medical director of Quest Diagnostics adds that colorectal cancer has a link to weight, and given adolescent obesity rates are on the rise, there could be a connection there.

  • 02042022
    Fierce Biotech

    Quest Diagnostics' longtime CEO Stephen Rusckowski seems to be taking the old adage to "quit while you're ahead" very seriously. On Thursday, the same day that it published a 2021 earnings report illustrating what was easily its strongest year yet, the lab testing giant announced that Rusckowski will step down from his place at the helm at the end of October.

  • 02032022
    The Claman Countdown | Fox Business

    Steve Rusckowski discusses how the omicron variant impacted Q4 earnings on 'The Claman Countdown.'

  • 02032022
    CNBC

    The at-home testing market is bigger than just Covid tests, and it's bigger than over-the-counter pregnancy tests. In fact, the emerging marketplace of consumer-initiated lab testing may be worth more than $2 billion by 2025, according to Quest Diagnostics.

Show 5102550100 per page